期刊文献+

单病例随机对照试验的起源与发展 被引量:9

An introduction of the origin and development of N-of-1 trials
原文传递
导出
摘要 随着临床试验研究的理论体系和方法学的完善,单病例随机对照试验作为一种以病人为中心的个体化临床试验研究手段,在全球范围内迅速发展。本文对单病例随机对照试验的起源与发展进行了全面介绍,以期帮助医学研究人员和临床工作者更好地了解、掌握、研究和应用单病例随机对照试验方法,从而提高医学临床研究的质量和临床疾病诊治的效果。 N-of- 1 trial is globally making rapid development as a patient-oriented individualized method with the development and improvement of methodology in clinical trial. The paper described the origin and development of N-of-1 trial, so as to help improve awareness among medical researchers and clinicians, and improve the clinical medical quality and level of clinical diagnosis and treatment.
作者 李江 翟静波 商洪才 陈静 石菊芳 杨克虎 田金徽 代敏 LI Jiang ZHAI Jingbo SHANG Hongcai CHEN Jing SHI Jufang YANG Kehu TIAN Jinhui DAI Min(Program office for Cancer Screening in Urban China, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P.R.China Traditional Chinese Medicine of Tianjin University, Tianfin, 300193, P.R.China Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beifing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Belting, 100700, P.R. China Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, P.R.China)
出处 《中国循证医学杂志》 CSCD 2017年第2期235-238,共4页 Chinese Journal of Evidence-based Medicine
基金 国家自然科学基金(编号:81602930 81273935)
关键词 单病例随机对照试验 起源 发展 N-of-1 trial Origin Development
  • 相关文献

参考文献1

二级参考文献15

  • 1Agency for Healthcare Research and Quality. Methods guide for effectiveness and comparative effectiveness re- views[M/OL]. Rockville, MD: AHRQ Publication No. 10 (12)-EHC063-EF, April 2012. Chapters are available at www.effectivehealthcare.ahrq.gov.
  • 2Guyatt G, Sackett D, Taylor D W, et al. Determining opti- mal therapy-randomized trials in individual patients[J]. N Engl J Med, 1986, 314(14): 889-892.
  • 3Guyatt G H, Haynes R B, Jaeschke R Z, et al. Users' guides to the medical literature XXV evidence-based med- icine: principles for applying the users' guides to patientcare[J]. Evidence-Based Medicine Working Group. JAMA, 2000, 284(10): 1290-1296.
  • 4Zucker D R, Deo A, Schmid C H. Dialysis research and N- of- 1 trials: made for each other?[J]. American Journal of Kidney Diseases, 2010, 55(4): 635-638.
  • 5Johnston B C, Mills E. N-of-1 randomized controlled trials: an oppommity for complementary and alternative medicine evaluation[J]. J Altern Complement Med, 2004, 10(6): 979-984.
  • 6Nikles J, Mitchell G K, Clavarino A, et al. Stakeholders' views on the routine use of N-of-1 trials to improve clini- cal care and to make resource allocation decisions for drug use[J]. Aust Health Rev, 2010, 34(1): 131-136.
  • 7Scuffham P A, Nikles J, Mitchell G K, et al. Using N-of-1 trials to improve patient management and save costs[J]. J Gen Intern Med, 2010, 25(9): 906-913.
  • 8Guyatt G. N of 1 randomized trials: a commentary[J]. J Clin Epidemiol, 2016 Apr5.pii: S0895-4356(16)30066-X.
  • 9Kravitz R L, Duan N. Design and implementation of N-of-1 trials: a user' s guide[M/OL]. AHRQ Publication No. 13(14)- EHC122-EF. Rockville, MD: Agency for Healthcare Research and Quality, 2014. http://www, ef- fectivehealthcare, ahrq. gov/N-1-Trials.cfm.
  • 10Vohra S, Shamseer L, Sampson M, et al; CENT Group. CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement[J]. J Clin Epidemiol, 2015 Aug 10. pii: S0895-4356(15)00225-5.

共引文献4

同被引文献113

引证文献9

二级引证文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部